Management of iatrogenic intravitreal triamcinolone acetonide.
Intravitreal corticossteroids have been used for therapeutic purposes in optimum doses and adverse reports have not been described. To best of our knowledge, this entity has never been reported as a problem. We report a case of successful management of iatrogenic intravitreal triamcinolone acetonide for intermediate uveitis. This case study highlights the strategy of appropriate and timely surgical management.
Kumar
Atul
A
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. akum66mm@ndf.vsnl.net.in
Prakash
Gunjan
G
Nainiwal
Sanjeev
S
D000328:Adult; D005131:Eye Injuries / Q000209:etiology / Q000601:surgery; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007049:Iatrogenic Disease; D007267:Injections / Q000009:adverse effects; D008297:Male; D013508:Ophthalmologic Surgical Procedures; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D015867:Uveitis, Intermediate / Q000188:drug therapy*; D014822:Vitreous Body; D014950:Wounds, Penetrating / Q000209:etiology / Q000601:surgery
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide